Even at doses 30 times lower than what was previously required, the therapy eased symptoms and did not cause harmful reactions.

The treatment worked at a dose 30 times lower than previous LNA therapies, and no side effects were observed.

The study calls for a closer examination of how disruptions to the circadian clock influence IBD and advocates for the development of innovative treatments that align with natural biological cycles.